Ryota Watano
Shimotsuke, 3290498, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
KRAS (G12D)-selective inhibitor MRTX1133 suppresses proliferation and differentially modulates chemosensitivity in ovarian mucinous carcinoma.
Journal: Oncology letters
Published: December 19, 2025
Limitation of Assay Sensitivity Revealed by the Improvement of Cell-Based Assay Against Various Adeno-Associated Virus Serotypes.
Journal: Human gene therapy
Published: May 19, 2025
Therapeutic Strategy for Fabry Disease by Intravenous Administration of Adeno-Associated Virus 9 in a Symptomatic Mouse Model.
Journal: Human gene therapy
Published: February 22, 2024
Adeno-associated Virus-mediated Ezh2 Knockdown Reduced the Increment of Newborn Neurons Induced by Forebrain Ischemia in Gerbil Dentate Gyrus.
Journal: Molecular neurobiology
Published: January 26, 2024
Therapeutic strategy for Fabry disease by intravenous administration of adeno-associated virus 2 or 9 in α-galactosidase A-deficient mice.
Journal: The journal of gene medicine
Published: July 29, 2022
The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs.
Journal: Molecular therapy. Methods & clinical development
Published: June 21, 2022
Utility of microminipigs for evaluating liver-mediated gene expression in the presence of neutralizing antibody against vector capsid.
Journal: Gene therapy
Published: July 27, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026